Marksans Pharma Limited · NSE: MARKSANS · BSE: 524404
Marksans Pharma
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 12 Aug 2026.
Q1 FY27 · Consolidated
Revenue
840.80₹ Cr
+35.6% vs year ago
Net profit
159.41₹ Cr
+173.9% vs year ago
EPS, basic
3.47₹
+169.0% vs year ago
Net margin
19.0%
+9.6 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 840.80 | +35.6% | 159.41 | +173.9% | 3.47 | 12 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 856.11 | 12x | 149.03 | 16x | 3.27 | 26 May 2026 |
| Q3 FY26Oct–Dec 2025 | 754.43 | +10.6% | 113.69 | +8.2% | 2.50 | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 720.41 | +12.2% | 99.14 | +1.4% | 2.17 | 13 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 619.99 | +5.0% | 58.20 | −34.7% | 1.29 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 70.85 | −87.3% | 9.07 | −88.3% | 2.00 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 681.85 | +16.3% | 105.07 | +26.6% | 2.31 | 11 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 641.92 | +20.8% | 97.76 | +16.6% | 2.13 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 590.62 | +18.1% | 89.07 | +26.4% | 1.96 | 14 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 560.01 | +15.2% | 77.64 | −6.1% | 1.73 | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 586.13 | +22.2% | 82.97 | +33.2% | 1.84 | 14 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 531.24 | +17.4% | 83.85 | +39.5% | 1.84 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 500.03 | +15.3% | 70.44 | +17.0% | 1.52 | 11 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 485.98 | +16.3% | 82.71 | +178.9% | 1.97 | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 479.83 | +32.3% | 62.31 | +29.1% | 1.56 | 13 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 452.56 | +25.3% | 60.12 | +29.9% | 1.52 | 16 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 433.77 | +24.3% | 60.18 | −3.9% | 1.46 | 16 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 418.04 | +26.6% | 29.65 | −62.7% | 0.69 | 31 May 2022 |
| Q3 FY22Oct–Dec 2021 | 362.63 | +1.2% | 48.27 | −18.1% | 1.20 | 11 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 361.20 | +1.3% | 46.29 | −8.8% | 1.11 | 10 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 348.96 | +5.4% | 62.60 | +26.8% | 1.51 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 330.20 | −1.5% | 79.50 | +86.0% | 1.93 | 01 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 358.36 | +24.6% | 58.94 | +99.4% | 1.42 | 08 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 356.47 | +39.0% | 50.73 | +95.4% | 1.21 | 09 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 331.15 | +35.1% | 49.37 | +119.6% | 1.20 | 08 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 335.35 | +35.5% | 42.74 | +333.8% | 1.00 | 02 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 287.65 | +15.8% | 29.56 | +17.6% | 0.71 | 12 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 256.40 | −4.7% | 25.97 | +26.2% | 0.63 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 245.03 | +4.2% | 22.48 | −9.6% | 0.52 | 12 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 247.41 | — | 9.85 | — | 0.21 | 06 Jun 2019 |
| Q3 FY19Oct–Dec 2018 | 248.37 | — | 25.13 | — | 0.60 | 09 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 269.04 | — | 20.57 | — | 0.48 | 17 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 235.25 | — | 24.88 | — | 0.58 | 06 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 321.19 | +0.5% | 69.04 | +43.7% | 1.52 | 12 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 361.57 | +20.8% | 91.92 | +144.5% | 2.03 | 26 May 2026 |
| Q3 FY26Oct–Dec 2025 | 339.73 | +8.9% | 60.91 | +9.8% | 1.34 | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 320.44 | +3.8% | 99.81 | +57.9% | 2.20 | 13 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 319.73 | +25.6% | 48.06 | +50.1% | 1.06 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 299.36 | +32.9% | 37.59 | +13.9% | 0.83 | 28 May 2025 |
| Q3 FY25Oct–Dec 2024 | 311.87 | +29.2% | 55.46 | +119.3% | 1.22 | 11 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 308.62 | +50.8% | 63.20 | +102.0% | 1.39 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 254.53 | +39.8% | 32.02 | −27.6% | 0.71 | 14 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 225.20 | +47.1% | 32.99 | +85.3% | 0.73 | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 241.36 | +39.7% | 25.29 | −1.3% | 0.56 | 14 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 204.67 | +20.2% | 31.29 | −22.2% | 0.69 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 182.04 | +14.4% | 44.19 | +130.1% | 0.98 | 11 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 153.04 | −13.2% | 17.81 | −16.9% | 0.43 | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 172.75 | +4.1% | 25.62 | −1.7% | 0.63 | 13 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 170.26 | +0.8% | 40.23 | +45.8% | 1.00 | 16 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 159.15 | +8.1% | 19.21 | −33.6% | 0.47 | 16 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 176.28 | +28.1% | 21.43 | −9.5% | 0.52 | 31 May 2022 |
| Q3 FY22Oct–Dec 2021 | 165.94 | −1.5% | 26.06 | −10.5% | 0.64 | 11 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 168.85 | +22.8% | 27.60 | +17.3% | 0.67 | 10 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 147.22 | −5.6% | 28.91 | +31.1% | 0.71 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 137.58 | +21.1% | 23.69 | +219.6% | 0.58 | 01 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 168.46 | +44.1% | 29.10 | +124.3% | 0.71 | 08 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 137.55 | +36.6% | 23.53 | +98.4% | 0.57 | 09 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 155.96 | +68.8% | 22.06 | +290.0% | 0.54 | 08 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 113.64 | +24.6% | 7.41 | +31.8% | 0.18 | 02 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 116.88 | −6.6% | 12.97 | +10.1% | 0.32 | 12 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 100.72 | −12.2% | 11.86 | −3.9% | 0.29 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 92.42 | −0.8% | 5.66 | −59.2% | 0.14 | 12 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 91.18 | — | 5.62 | — | 0.14 | 06 Jun 2019 |
| Q3 FY19Oct–Dec 2018 | 125.19 | — | 11.78 | — | 0.29 | 09 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 114.65 | — | 12.34 | — | 0.30 | 17 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 93.14 | — | 13.87 | — | 0.34 | 06 Aug 2018 |
66 filings on record for this company.